Apple May Remove Blood Oxygen Feature from Watches to Avoid US Import Ban

The tech giant is still awaiting a decision from a US Court of Appeals on whether it can continue selling the devices with the blood oxygen tech during the remainder of the appeals process.

Apple is considering removing the blood oxygen feature from its Series 9 and Ultra 2 watches to avoid a US import ban, following a patent dispute with medical technology firm Masimo.
Apple has reportedly begun sending updated versions of the watches, without the blood oxygen feature, to its US stores.
The US Customs and Border Protection agency has agreed that a redesigned Apple Watch without the blood oxygen monitoring tech falls outside of the scope of the International Trade Commission’s import and sales ban.
Apple is still awaiting a decision from a US Court of Appeals on whether it will be granted a permanent stay to continue selling the devices with the blood oxygen tech during the remainder of the appeals process.
Despite the potential removal of the feature, existing Apple Watch owners are not expected to lose the blood oxygen functionality in an update.

Interesting Engineering